Reach Catalyst is more than just a clinical research services, functional service provider (FSP), and strategic resourcing organization.
ReachCatalyst is a mid-sized Clinical Research functional service provider (FSP), and strategic resources organization. headquartered in the United States and Japan with a significant presence across North America, Europe, and Asia-Pacific. ReachCatalyst provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
Reach Catalyst was established in June 2010 by a group of entrepreneurs at a major UK pharmaceutical supply company. In accordance with the industry philosophy of contributing to new drug development and promoting the well-being of patients, Reach Catalyst supports the clinical research goals of pharmaceutical and biotechnology companies. Given the exponential globalization of large-scale pharmaceutical product development, Reach Catalyst has actively expanded its activities around the world, to become the first Japanese Headquartered Global Functional Service Provider (FSP) Consultant capable of delivering a one-stop service for large-scale, global projects.
​
Reach Catalyst is an award-winning FSP consultant and recruiter and has been honored as a Award nominee for Best Functional Service Provider (FSP) Consultant by industry leaders for 11 consecutive years, after being evaluated against global CROs for quality of services, performance, client satisfaction, Sponsor relationships, and the overall value brought to study Sponsors. Additionally, Presented by Life Science Leader and Clinical Leader, the Awards evaluated over 60 contract research organizations on more than 20 performance metrics in ISR’s annual Functional Service Provider (FSP) Consultant Quality Benchmarking survey. Reach Catalyst was also recently honored with the 2020 and 2021 Global Excellence Awards for Most Innovative CRO by Global Health & Pharma Magazine (GHP) and Most Outstanding Contract Research Service Provider 2021 for Full-Service Drug Development in Acquisition International Magazine's Global Excellence Awards.
Mission
At ReachCatalyst, we are the right sized, global CRO to deliver innovative solutions for even the most complex industry challenges. We provide our clients with the personal attention, flexibility, and reach needed for a continually evolving pharmaceutical and biotech market. We believe in supporting clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world.
Mission
ReachCatalyst will be the CRO of choice among the global, mid-sized CRO market. We will achieve this by continuing to expand our current geographical reach into additional parts of the world, enabling us to thoughtfully partner with our clients anywhere their clinical development endeavors take them. While strategically growing our business, we are committed to maintaining the personal, attentive service our clients, employees, and patients deserve.
Values
To promote the greater wellbeing of all our stakeholders
patients, business partners, shareholders, and employees
we strive constantly to offer professional, high-quality services
200+
Dedicated Profetional
to support all aspects of new drug development.